Comparable stake leader
Northpond Ventures GP, LLC
SEC ownership of DICE Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001645569.
Disclosed value leader
Northpond Ventures GP, LLC
Comparable rows
0/1
Latest evidence
22 Jun 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Northpond Ventures GP, LLC
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
22 Jun 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001645569
- Issuer location
- South San Francisco, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of DICE Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Northpond Ventures GP, LLC
Disclosed value leader
Northpond Ventures GP, LLC
Comparable rows
0/1
Latest evidence
22 Jun 2023
3/4/5
Highest disclosed value: $37,200,001
1 rows are not safely comparable across share classes.
Quick read
Northpond Ventures GP, LLC has the largest disclosed position value at $37.2M.
0 of 1 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Northpond Ventures GP, LLC's linked filing trail.
Disclosed position value
Top 1
Northpond Ventures GP, LLC
$37.2M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-1 of 1 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Northpond Ventures GP, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$37,200,001
800,000 shares
|
— | 22 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to DICE Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Northpond Ventures GP, LLC
Net 12M change
$0
Latest report
09 Aug 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Northpond Ventures GP, LLC | 10%+ Owner | $37,200,001 | Filing P/S | 22 Jun 2023 | ||
| Lisa Bowers | Director | Mixed | 09 Aug 2023 | |||
| Richard H. Scheller | Director | Mixed | 09 Aug 2023 | |||
| James Paul Scopa | Director | Mixed | 09 Aug 2023 | |||
| Kevin Judice | CEO, Director | Mixed | 09 Aug 2023 | |||
| Scott M. Robertson | Cfo & Cbo | Mixed | 09 Aug 2023 | |||
| Jake Simson | Director | Mixed | 09 Aug 2023 | |||
| Stephen Zachary | Director | Mixed | 14 Sep 2021 | |||
| Mittie Doyle | Director | Mixed | 09 Aug 2023 | |||
| Timothy Lu | Cmo | Mixed | 09 Aug 2023 | |||
| RA CAPITAL MANAGEMENT, L.P. | Former 10% owners and Director | Mixed | 09 Aug 2023 | |||
| Sharon Tetlow | Director | Mixed | 09 Aug 2023 | |||
| John R. Jacobsen | Cso | Mixed | 09 Aug 2023 | |||
| Shaan-Chirag C. Gandhi | Director | Mixed | 14 Sep 2021 |
Recent insider transactions for DICE Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.